Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12261307 | 0.91 | OPRM1 (0.38) | DNM1OPRM1 | |
| SCHEMBL16576438 | 0.91 | OPRM1 (0.38) | DNM1OPRM1 | |
| SCHEMBL15199078 | 0.85 | OPRM1 (0.33) | DNM1OPRM1 | |
| SCHEMBL728957 | 0.75 | — | — | |
| SCHEMBL15199076 | 0.75 | — | — | |
| SCHEMBL15868427 | 0.72 | DNM1 (0.39) | DNM1OPRM1 | |
| SCHEMBL27482199 | 0.71 | OPRM1 (0.39) | DNM1OPRM1 | |
| SCHEMBL16749029 | 0.70 | — | — | |
| SCHEMBL10537330 | 0.70 | DNM1 (0.30) | DNM1 | |
| SCHEMBL690366 | 0.69 | ALDH1A1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2011527341-A | — | — | 2011-10-27 | — | — | JP | claimed |
| US-8017687-B2 | Swollen silicone composition and process of producing same | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2011-09-13 | — | — | US | claimed |
| EP-2296667-A2 | SILICONE COMPOSITION | Momentive Performance Materials Inc. (US) | 2011-03-23 | — | — | EP | claimed |
| EP-2228053-A1 | Swollen silicone composition and process of producing same | Momentive Performance Materials Inc. (US) | 2010-09-15 | — | — | EP | claimed |
| JP-2010515566-A | — | — | 2010-05-13 | — | — | JP | claimed |
| WO-2010005538-A2 | SILICONE COMPOSITION | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2010-01-14 | — | — | WO | claimed |
| US-20100003201-A1 | Silicone composition | MOMENTIVE PERFORMANCE MATERIALS, INC. | 2010-01-07 | — | — | US | claimed |
| EP-2108028-A2 | METHOD OF APPLYING A COMPOSITION | Momentive Performance Materials Inc. (US) | 2009-10-14 | — | — | EP | claimed |
| JP-2009516024-A | — | — | 2009-04-16 | — | — | JP | claimed |
| EP-1962791-A1 | SWOLLEN SILICONE COMPOSITION, PROCESS OF PRODUCING SAME AND PRODUCTS THEREOF | Momentive Performance Materials Inc. (US) | 2008-09-03 | — | — | EP | claimed |
| WO-2008088323-A2 | METHOD OF APPLYING A COMPOSITION | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2008-07-24 | — | — | WO | claimed |
| US-20070160547-A1 | Method of applying a composition | MOMENTIVE PERFORMANCE MATERIALS INC. | 2007-07-12 | — | — | US | claimed |
| WO-2007061623-A1 | SWOLLEN SILICONE COMPOSITION, PROCESS OF PRODUCING SAME AND PRODUCTS THEREOF | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070112146-A1 | Swollen silicone composition, process of producing same and products thereof | MOMENTIVE PERFORMANCE MATERIALS INC. | 2007-05-17 | — | — | US | claimed |
| US-20070112112-A1 | Swollen silicone composition and process of producing same | MOMENTIVE PERFORMANCE MATERIALS INC. | 2007-05-17 | — | — | US | claimed |
| EP-1620068-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2006-02-01 | — | — | EP | claimed |
| WO-2004087077-A1 | COSMETIC COMPOSITION COMPRISING A VOLATILE FATTY PHASE | L'OREAL (FR) | 2004-10-14 | — | — | WO | claimed |
| US-20040197284-A1 | Cosmetic composition comprising a volatile fatty phase | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | claimed |
| EP-3768762-B1 | SILICONE POLYMER | MOMENTIVE PERFORMANCE MAT INC (US) | 2025-02-19 | — | — | EP | disclosed |
| US-20040197284-A1 | Cosmetic composition comprising a volatile fatty phase | L'OREAL S.A. (FR) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100003201-A1 | Silicone composition | CUTA, SMURF1, MMS19 | DNM1 3445/4885OPRM1 4733/4885 |
| US-20070112146-A1 | Swollen silicone composition, process of producing same and products thereof | PIEZO1, SMS, ALG3 | DNM1 4596/4885OPRM1 3508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.